Drugs and medical devices authorized, April 1 to June 30, 2026
From April 1 to June 30, 2026, Health Canada approved 15 new drug submissions (8 pharmaceuticals, 7 biologics) and 481 new medical devices, including 22 Class IV medical devices, which present the greatest potential risk. During this period, Health Canada also approved 31 generic drugs and 10 biosimilar drugs.
From April 1 to June 30, 2026, Health Canada approved 15 new drug submissions (8 pharmaceuticals, 7 biologics) and 481 new medical devices, including 22 Class IV medical devices, which present the greatest potential risk. During this period, Health Canada also approved 31 generic drugs and 10 biosimilar drugs.
For more information on these and other drug and medical device approvals, consult:
This is an extract. The publication continues at the source.
Read the original at the source: https://www.canada.ca/en/health-canada/news/2026/07/drugs-and-medical-devices-authorized-april-1-to-june-30-2026.html
Officially imported this from Health Canada’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Health Canada — imported from official source
- Official source
- https://api.io.canada.ca/io-server/gc/news/en/v2?dept=departmentofhealth&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Health%20Canada ATOM
- Imported
- October 03, 2026 20:43
- Versions
- 1 recorded
- Identity
https://www.canada.ca/en/health-canada/news/2026/07/drugs-and-medical-devices-authorize...